Sanwa BioTech delivers accurate and actionable diagnostic information through our Point-Of-Care (POC) platform -ALiAand BioChip. It combines Lab-On-Chip and Microarray technologies resulting in transformative diagnostics for faster clinical decisions. We formed basis for this concept of bringing forth a multi-target POC solution for diagnosis of time critical and life-threatening diseases.

ALiAis an end-to-end solution to delivers multiple results in 15 minutes for front-line physicians. The ALiAsystem includes an IVD device and a disposable microfluidic Lab-On-Chip (LOC) to auto-process an immunoassay on a protein microarray. It is a small and mobile platform that provides accurate assay anywhere. While diagnostics through lab process takes time to wait and causes proper medication delay, ALiAcan provide multiple results beside patients with small volume of sample according to specific symptoms and assist physicians to make decision promptly.

At Sanwa BioTech, we believe that impending changes are coming to the way to conventional clinical diagnostic & academic R&D for bio-discoveries.